Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Medicine (Baltimore) ; 100(14): e24969, 2021 Apr 09.
Artigo em Inglês | MEDLINE | ID: mdl-33832071

RESUMO

ABSTRACT: Pancreatic cancer has a very high mortality with a 5-year survival of <5%. The purpose of this study was to classify specific molecular subtypes associated with prognosis of pancreatic cancer using The Cancer Genome Atlas (TCGA) multiplatform genomic data.Multiplatform genomic data (N = 178), including gene expression, copy number alteration, and somatic mutation data, were obtained from cancer browser (https://genome-cancer.ucsc.edu, cohort: TCGA Pancreatic Cancer). Clinical data including survival results were analyzed. We also used validation cohort (GSE50827) to confirm the robustness of these molecular subtypes in pancreatic cancer.When we performed unsupervised clustering using TCGA gene expression data, we found three distinct molecular subtypes associated with different survival results. Copy number alteration and somatic mutation data showed different genomic patterns for these three subtypes. Ingenuity pathway analysis revealed that each subtype showed differentially altered pathways. Using each subtype-specific genes (200 were selected), we could predict molecular subtype in another cohort, confirming the robustness of these molecular subtypes of pancreatic cancer. Cox regression analysis revealed that molecular subtype is the only significant prognostic factor for pancreatic cancer (P = .042, 95% confidence interval 0.523-0.98).Genomic analysis of pancreatic cancer revealed 3 distinct molecular subtypes associated with different survival results. Using these subtype-specific genes and prediction model, we could predict molecular subtype associated with prognosis of pancreatic cancer.


Assuntos
Genômica/métodos , Neoplasias Pancreáticas/genética , Idoso , Biomarcadores Tumorais/genética , Variações do Número de Cópias de DNA , Bases de Dados Factuais , Feminino , Perfilação da Expressão Gênica/métodos , Humanos , Masculino , Pessoa de Meia-Idade , Neoplasias Pancreáticas/classificação , Neoplasias Pancreáticas/mortalidade , Estudos Retrospectivos , Transdução de Sinais , Neoplasias Pancreáticas
2.
Eye Contact Lens ; 46(4): 223-227, 2020 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-32443003

RESUMO

PURPOSE: To investigate the presentation, clinical characteristics, and outcomes of Acanthamoeba keratitis (AK) in Busan, South Korea, over a 5-year period. METHODS: This retrospective study involved a review of the medical records of 16 patients (19 eyes in total) who were diagnosed with AK, related to wearing contact lenses, at the tertiary hospital, Pusan National University Hospital at Busan City, from December 2013 to December 2018. RESULTS: Nineteen eyes of 16 patients with a diagnosis of AK were identified. The average age of the patients was 21.1±12.6 years; there were 2 men and 14 women. The mean period from the onset of the first symptoms to diagnosis was 7.0±6.5 days. The average initial visual acuity was 0.78±0.37 (tested on a logarithm of the minimum angle of resolution chart), and the final visual acuity after treatment was 0.07±0.07, indicating a significant improvement (P=0.001). A variety of corneal lesions were identified. Early diagnosis of AK was associated with a significantly better final visual acuity. CONCLUSION: The average therapeutic period for AK, when a surface epithelial lesion of the cornea was identified, was 4 months compared with an average period of over 6 months for a deeper stromal lesion. Therefore, this study highlights the fundamental importance of early diagnosis, preventing deeper layers of the cornea from being affected, and appropriate management to ensure a favorable outcome.


Assuntos
Ceratite por Acanthamoeba/etiologia , Lentes de Contato/efeitos adversos , Ceratite por Acanthamoeba/diagnóstico , Ceratite por Acanthamoeba/tratamento farmacológico , Ceratite por Acanthamoeba/fisiopatologia , Adolescente , Adulto , Antiprotozoários/uso terapêutico , Clorexidina/uso terapêutico , Feminino , Guanidinas/uso terapêutico , Humanos , Masculino , Microscopia Confocal , Polímeros/uso terapêutico , República da Coreia , Estudos Retrospectivos , Fatores de Risco , Transtornos da Visão/diagnóstico , Transtornos da Visão/tratamento farmacológico , Transtornos da Visão/etiologia , Transtornos da Visão/fisiopatologia , Acuidade Visual/fisiologia , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA